Discover our extensive collection of research-grade antibodies,
rigorously validated for in vivo applications.
Precisely identify antibody-specific signals using matched isotype controls optimised for in vivo experimentation.
BiosimilarsInvestigate biological therapeutic mechanisms with cost-effective, research-grade biosimilar antibodies.
Recombinant biosimilar antibodies are manufactured in an animal-free facility, utilizing exclusively in vitro, protein-free cell culture techniques, and undergo multi-step purification that incorporates Protein A or G (chromatography) processes.
| Product Name | BioSIM anti-Human SLAMF7/CS1 Antibody (Azintuxizumab Biosimilar), Research Grade |
| Size | 1mg/5mg |
| Isotype | / |
| Target | SLAMF7/CS1 |
| Other Names | ABBV-383, PR-1471272, ABBV-838, CAS: 1826819-57-1 |
| CAS | 1826819-57-1 |
| Reactivity | Human |
| Host Species | Humanized |
| Background | Recombinant biosimilar antibodies are manufactured in an animal-free facility, utilizing exclusively in vitro, protein-free cell culture techniques, and undergo multi-step purification that incorporates Protein A or G (chromatography) processes. |
| Applications | ELISA, FACS, Functional assay, Research in vivo |
| Purification | Protein A/G |
| Storage | To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Shipping | 2-8°C with blue ice |
| Concentration | Lot specific, generally ≥ 5.0 mg/ml |
| Shelf Life | 12 months from the date of receipt if stored as recommended |
| Formulation | PBS, pH 7.4, contains no stabilizers or preservatives |
| Sterility | 0.2 μM filtered |
| Endotoxin | ≤ 1.0 EU/mg |
| Purity | 99% |
© 2021-2025 InvivoCrown Limited. All rights reserved.